India  

Oxford Covid-19 vaccine approved for UK use

Video Credit: PA - Press Association STUDIO - Duration: 00:53s - Published
Oxford Covid-19 vaccine approved for UK use

Oxford Covid-19 vaccine approved for UK use

A Covid-19 vaccine from Oxford University and AstraZeneca has been approvedfor use in the UK, paving the way for rapid rollout, the Department of Healthsaid.


You Might Like


💡 newsR Knowledge: Other News Mentions

Oxford Oxford City and non-metropolitan district in England

Watch: UK PM Boris Johnson gets his first jab of AstraZeneca Covid-19 vaccine [Video]

Watch: UK PM Boris Johnson gets his first jab of AstraZeneca Covid-19 vaccine

British PM Boris Johnson received his first dose of AstraZeneca's Covid vaccine on Friday. The 56-year-old UK PM took to Twitter and shared a video urging the public to do the same. Johnson received the jab at Gassiot House Outpatient Centre in London's St Thomas' Hospital. Last year, Johnson was diagnosed with Covid and was admitted to the hospital for treatment. Johnson had spent a week at St Thomas' Hospital including three days in intensive care. AstraZeneca's jab, developed with Oxford, provides the bulk of Britain's inoculation campaign. A large portion of its supply has also been produced by the Serum Institute of India.

Credit: HT Digital Content    Duration: 02:03Published

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases [Video]

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila Health said, "The drug has also shown efficacy against other viral infections."Speaking on the development, Dr Sharvil Patel, Managing Director, Cadila Healthcare Limited said: "The fact that we are able to offer a therapy which significantly reduces viral load when given early on can help in better disease management. It comes at a much-needed time for patients and we will continue to provide them access to critical therapies in this battle against COVID-19." This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark. India recorded 3,32,730 new COVID-19 cases in the last 24 hours, the highest single-day spike since the pandemic broke out last year. India has crossed the mark of 3 lakh COVID-19 cases for two consecutive days now. This has taken the cumulative count of the COVID infection in the country to 1,62,63,695.

Credit: ANI    Duration: 02:01Published
PM Modi holds meeting with oxygen manufacturers [Video]

PM Modi holds meeting with oxygen manufacturers

Prime Minister Narendra Modi held a meeting with oxygen manufacturers in the country via video-conferencing on April 23. The meeting was attended by Reliance, Tata Steels, SAIL, etc. Requirement of oxygen has soared in hospitals in the country due to COVID situation.

Credit: ANI    Duration: 01:13Published

Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment

Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon..
IndiaTimes
UEFA to issue verdict on Euro 2020 hosting cities as Munich, Dublin and Bilbao face exclusion [Video]

UEFA to issue verdict on Euro 2020 hosting cities as Munich, Dublin and Bilbao face exclusion

UEFA asked hosting cities to open at least 25% of their stadiums to fans, but not all of them are able to do so amid COVID-19 restrictions.

Credit: Euronews English    Duration: 00:38Published

AstraZeneca British-Swedish pharmaceutical company

EU plays down claim that a legal case has been launched against AstraZeneca [Video]

EU plays down claim that a legal case has been launched against AstraZeneca

Irish health minister Stephen Donnelly said the European Commission would take legal action against the vaccine producer, but Brussels played down the claim.

Credit: Euronews English    Duration: 01:53Published

EU takes legal action against AstraZeneca over vaccine supply

A legal case has been started by the European Commission against AstraZeneca over its "complete failure" to meet delivery and contractual agreements, Ireland's..
Sky News
Syria’s Idlib region receives first batch of COVID-19 vaccines [Video]

Syria’s Idlib region receives first batch of COVID-19 vaccines

Some 53,800 doses of the AstraZeneca vaccine were distributed in the last rebel-held enclave on Wednesday, a UN official said.

Credit: Al Jazeera STUDIO    Duration: 02:07Published

University of Oxford University of Oxford Collegiate research university in Oxford, England

How big is risk of clots from Covishield?

The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can be treated if..
IndiaTimes

Family of Italian woman who died after Oxford jab launch legal action

The family of an Italian woman who died weeks after having the Oxford-AstraZeneca coronavirus vaccine have told Sky News they are taking legal action to..
Sky News
How do people feel about the AstraZeneca vaccine? [Video]

How do people feel about the AstraZeneca vaccine?

Under-30s in the UK will be offered Pfizer or Moderna vaccines rather than the Oxford/AstraZeneca vaccine due to concerns over a very rare risk of blood clots. The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said there were still huge benefits of the vaccine in preventing Covid-19, and has not concluded that the vaccine causes rare clots, although it says the link is getting firmer. Report by Patelr. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:05Published

Risk of blood clot after COVID is eight times higher than after AstraZeneca jab - study

The risk of developing a blood clot after having COVID-19 is eight times higher than after being given the Oxford-AstraZeneca vaccine, according to a study by..
Sky News

Related news from verified sources

COVID-19: UK approves use of AstraZeneca-Oxford vaccine, all eyes on India now

Britain on Wednesday (December 30) approved Oxford-Astrazeneca coronavirus vaccine for use against...
Zee News - Published Also reported by •IndiaTimesHindu


India will have COVID-19 vaccine within days: AIIMS director

Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS...
Mid-Day - Published

Oxford Covid-19 vaccine may become the first to get Indian regulator's nod for emergency use

Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on Covid-19...
IndiaTimes - Published


Related videos from verified sources

China gives conditional approval to vaccine [Video]

China gives conditional approval to vaccine

China approved a COVID-19 vaccine developed by an affiliate of state-backed pharmaceutical giant Sinopharm on Thursday, making it the country's first approved shot for general public use, as it braces..

Credit: Reuters Studio     Duration: 00:58Published
How does the AstraZeneca/Oxford vaccine work? [Video]

How does the AstraZeneca/Oxford vaccine work?

The AstraZeneca/Oxford University vaccine has become the latest coronavirusjab approved for use in the UK. We take a look at how it works.

Credit: PA - Press Association STUDIO     Duration: 01:48Published
COVID vaccine: UK approves AstraZeneca/Oxford University coronavirus jab for use [Video]

COVID vaccine: UK approves AstraZeneca/Oxford University coronavirus jab for use

The UK has ordered 100 million doses from AstraZeneca, which can vaccinate 50 million people.

Credit: Euronews English     Duration: 02:58Published